Practical recommendations on quantifying and interpreting treatment effects in the presence of terminal competing risks.
3 Dec, 2021 | 10:07h | UTCPractical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A Review – JAMA Cardiology (free for a limited period)
Commentary on Twitter
Our paper on how to analyze and interpret terminal competing risks in cardiovascular clinical trials just out in JAMA Cardiology. Always a pleasure to collaborate with LJ Wei, Marc Pfeffer and Scott Solomon and their great teams. https://t.co/9hk6wru7yU pic.twitter.com/64sgoOjldQ
— Otavio Berwanger (@OtavioBerwanger) December 1, 2021